Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Depreciation and Depletion (2016 - 2026)

Amphastar Pharmaceuticals has reported Depreciation and Depletion over the past 13 years, most recently at $8.1 million for Q4 2025.

  • For Q4 2025, Depreciation and Depletion rose 11.22% year-over-year to $8.1 million; the TTM value through Dec 2025 reached $31.6 million, up 12.03%, while the annual FY2025 figure was $31.6 million, 12.03% up from the prior year.
  • Depreciation and Depletion for Q4 2025 was $8.1 million at Amphastar Pharmaceuticals, up from $7.9 million in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $8.3 million in Q2 2025 and troughed at $5.4 million in Q3 2021.
  • A 5-year average of $6.6 million and a median of $6.3 million in 2023 define the central range for Depreciation and Depletion.
  • On a YoY basis, Depreciation and Depletion climbed as much as 20.57% in 2021 and fell as far as 2.69% in 2021.
  • Year by year, Depreciation and Depletion stood at $5.4 million in 2021, then increased by 14.62% to $6.2 million in 2022, then increased by 7.37% to $6.6 million in 2023, then increased by 9.28% to $7.3 million in 2024, then rose by 11.22% to $8.1 million in 2025.
  • Business Quant data shows Depreciation and Depletion for AMPH at $8.1 million in Q4 2025, $7.9 million in Q3 2025, and $8.3 million in Q2 2025.